Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas

被引:5
|
作者
Johnson, K. J. [1 ,2 ]
Fisher, M. J. [4 ,5 ]
Listernick, R. L. [6 ]
North, K. N. [7 ]
Schorry, E. K. [8 ]
Viskochil, D. [9 ]
Weinstein, M. [10 ]
Rubin, J. B. [3 ]
Gutmann, D. H. [11 ]
机构
[1] Washington Univ, Publ Hlth Program, George Warren Brown Sch, St Louis, MO 63130 USA
[2] Washington Univ, Brown Sch, St Louis, MO 63130 USA
[3] Washington Univ, Dept Pediat, Sch Med, Div Pediat Hematol Oncol, St Louis, MO 63130 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Dept Oncol, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[6] Childrens Mem Hosp, Chicago, IL 60614 USA
[7] Univ Sydney, Sydney, NSW 2006, Australia
[8] Cincinnati Childrens Hosp, Cincinnati, OH USA
[9] Univ Utah, Salt Lake City, UT USA
[10] Univ Toronto, Toronto, ON, Canada
[11] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA
关键词
Parent-of-origin; Neurofibromatosis type 1; Optic pathway glioma; Brain tumor; NF1; SEVERITY;
D O I
10.1007/s10689-012-9549-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant cancer syndromes worldwide. Individuals with NF1 have a wide variety of clinical features including a strongly increased risk for pediatric brain tumors. The etiology of pediatric brain tumor development in NF1 is largely unknown. Recent studies have highlighted the contribution of parent-of-origin effects to tumorigenesis in sporadic cancers and cancer predisposition syndromes; however, there is limited data on this effect for cancers arising in NF1. To increase our understanding of brain tumor development in NF1, we conducted a multi-center retrospective chart review of 240 individuals with familial NF1 who were diagnosed with a pediatric brain tumor (optic pathway glioma; OPG) to determine whether a parent-of-origin effect exists overall or by the patient's sex. Overall, 50 % of individuals with familial NF1 and an OPG inherited the NF1 gene from their mother. Similarly, by sex, both males and females were as likely to inherit the NF1 gene from their mother as from their father, with 52 % and 48 % of females and males with OPGs inheriting the NF1 gene from their mother. In conclusion, in contrast to findings from other studies of sporadic cancers and cancer predisposition syndromes, our results indicate no parent-of-origin effect overall or by patient sex for OPGs in NF1.
引用
收藏
页码:653 / 656
页数:4
相关论文
共 50 条
  • [41] Neurofibromatosis type I and optic pathway gliomas.: A series of 80 patients
    Pascual-Castroviejo, I.
    Pascual-Pascual, S. I.
    Velazquez-Fragua, R.
    Viano, J.
    Garcia-Segura, J. M.
    Botella, M. P.
    REVISTA DE NEUROLOGIA, 2008, 46 (09) : 530 - 536
  • [42] Feasibility and Comparison of Visual Acuity Testing Methods in Children with Neurofibromatosis Type 1 and/or Optic Pathway Gliomas
    Avery, Robert A.
    Bouffet, Eric
    Packer, Roger J.
    Reginald, Arun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (02) : 1034 - 1038
  • [43] EMERGENCE OF OPTIC PATHWAY GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AFTER NORMAL NEUROIMAGING RESULTS
    LISTERNICK, R
    CHARROW, J
    GREENWALD, M
    JOURNAL OF PEDIATRICS, 1992, 121 (04): : 584 - 587
  • [44] Unilateral Optic Pathway Gliomas in the Absence of Other Features of Neurofibromatosis Type 1 are not Suggestive of a Diagnosis of this Syndrome
    Wang, V.
    Reichman, L.
    Felton, K.
    Foulkes, W.
    Tabori, U.
    Malkin, D.
    Goudie, C.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S203 - S204
  • [45] Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study
    Santoro, Claudia
    Perrotta, Silverio
    Picariello, Stefania
    Scilipoti, Martina
    Cirillo, Mario
    Quaglietta, Lucia
    Cinalli, Giuseppe
    Cioffi, Daniela
    Di Iorgi, Natascia
    Maghnie, Mohamad
    Gallizia, Annalisa
    Parpagnoli, Maria
    Messa, Federica
    De Sanctis, Luisa
    Vannelli, Silvia
    Marzuillo, Pierluigi
    del Giudice, Emanuele Miraglia
    Grandone, Anna
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06): : E2214 - E2221
  • [46] Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas
    Marjanska, Agata
    Kubicka, Malgorzata
    Kurylo-Rafinska, Beata
    Jatczak-Gaca, Agnieszka
    Wysocki, Mariusz
    Styczynski, Jan
    ANTICANCER RESEARCH, 2019, 39 (11) : 6389 - 6392
  • [47] Trial Design for Identifying Biomarkers of Visual Function in Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1
    Johnson, Timothy Lemuel, II
    Smith, Zac Wennberg
    Garcia, Arielle
    Wink, Sallyanne
    Nunez, Mariana
    Wynne, Niamh
    Jiang, Yu You
    Morgan, Jessica Ijams Wolfing
    Norcia, Anthony M.
    Beres, Shannon J.
    Campen, Cynthia J.
    Avery, Robert A.
    Goldberg, Jeffrey Louis
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [48] OPTIC PATHWAY GLIOMA IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1
    Friedrich, R. E.
    Nuding, M.
    Feucht, M.
    Mautner, V. F.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6815 - 6816
  • [49] Characterization of optic gliomas utilizing neurofibromatosis type 1 mouse models
    Klesse, Laura
    Parada, L.
    NEURO-ONCOLOGY, 2008, 10 (03) : 461 - 461
  • [50] SCREENING FOR OPTIC GLIOMAS IN NEUROFIBROMATOSIS TYPE-1 - THE ROLE OF NEUROIMAGING
    CHAMPION, MP
    ROBINSON, RO
    JOURNAL OF PEDIATRICS, 1995, 127 (03): : 507 - 507